Alsheikh-Ali A et al. Circulation 2005; available at: http://circ.ahajournals.org.

1
Adverse events in postmarketing analysis of
statins, October 1, 2003-September 30, 2004
Outcome Rosuvastatin Simvastatin Pravastatin Atorvastatin
Adverse events (n) 145 381 52 315
Prescriptions (in millions) 5.2 29.8 15 72.9
Age (years) 59.6 65.3 66.3 62.1
Male () 55 63 69 46
Outcome ()        
Death 2 6 15 10
Hospitalization 72 76 83 66
No hospitalization 26 18 2 24
Alsheikh-Ali A et al. Circulation 2005 available
at http//circ.ahajournals.org.